225 related articles for article (PubMed ID: 21888505)
1. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.
Martínez-Montemayor MM; Acevedo RR; Otero-Franqui E; Cubano LA; Dharmawardhane SF
Nutr Cancer; 2011; 63(7):1085-94. PubMed ID: 21888505
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models.
Suarez-Arroyo IJ; Rosario-Acevedo R; Aguilar-Perez A; Clemente PL; Cubano LA; Serrano J; Schneider RJ; Martínez-Montemayor MM
PLoS One; 2013; 8(2):e57431. PubMed ID: 23468988
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
[TBL] [Abstract][Full Text] [Related]
4. PLEKHA7, an Apical Adherens Junction Protein, Suppresses Inflammatory Breast Cancer in the Context of High E-Cadherin and p120-Catenin Expression.
Pence LJ; Kourtidis A; Feathers RW; Haddad MT; Sotiriou S; Decker PA; Nassar A; Ocal IT; Shah SS; Anastasiadis PZ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525380
[TBL] [Abstract][Full Text] [Related]
5.
Acevedo-Díaz A; Ortiz-Soto G; Suárez-Arroyo IJ; Zayas-Santiago A; Martínez Montemayor MM
Nutrients; 2019 May; 11(5):. PubMed ID: 31109134
[TBL] [Abstract][Full Text] [Related]
6. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.
Silvera D; Arju R; Darvishian F; Levine PH; Zolfaghari L; Goldberg J; Hochman T; Formenti SC; Schneider RJ
Nat Cell Biol; 2009 Jul; 11(7):903-8. PubMed ID: 19525934
[TBL] [Abstract][Full Text] [Related]
7. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors.
Santiago-Sánchez GS; Noriega-Rivera R; Hernández-O'Farrill E; Valiyeva F; Quiñones-Diaz B; Villodre ES; Debeb BG; Rosado-Albacarys A; Vivas-Mejía PE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445288
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory breast cancer (IBC): clues for targeted therapies.
Fernandez SV; Robertson FM; Pei J; Aburto-Chumpitaz L; Mu Z; Chu K; Alpaugh RK; Huang Y; Cao Y; Ye Z; Cai KQ; Boley KM; Klein-Szanto AJ; Devarajan K; Addya S; Cristofanilli M
Breast Cancer Res Treat; 2013 Jul; 140(1):23-33. PubMed ID: 23784380
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
Rypens C; Marsan M; Van Berckelaer C; Billiet C; Melis K; Lopez SP; van Dam P; Devi GR; Finetti P; Ueno NT; Bertucci F; Dirix P; Neven P; Vermeulen P; Dirix L; Van Laere SJ
Breast Cancer Res Treat; 2020 Apr; 180(2):385-395. PubMed ID: 32043194
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Effects of a Triterpene-Enriched Extract from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), on Human Lung Cancer Cells.
Zolj S; Smith MP; Goines JC; Ali TS; Huff MO; Robinson DL; Lau JM
Int J Med Mushrooms; 2018; 20(12):1173-1183. PubMed ID: 30806298
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma Lucidum Polysaccharide, an Extract from Ganoderma Lucidum, Exerts Suppressive Effect on Cervical Cancer Cell Malignancy through Mitigating Epithelial-Mesenchymal and JAK/STAT5 Signaling Pathway.
Jin H; Song C; Zhao Z; Zhou G
Pharmacology; 2020; 105(7-8):461-470. PubMed ID: 31995806
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells.
Thyagarajan A; Zhu J; Sliva D
Int J Oncol; 2007 Apr; 30(4):963-9. PubMed ID: 17332936
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
15. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9.
Jiao C; Chen W; Tan X; Liang H; Li J; Yun H; He C; Chen J; Ma X; Xie Y; Yang BB
J Ethnopharmacol; 2020 Jan; 247():112256. PubMed ID: 31586690
[TBL] [Abstract][Full Text] [Related]
16.
Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
[No Abstract] [Full Text] [Related]
17. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
[TBL] [Abstract][Full Text] [Related]
18. Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment.
Barbieri A; Quagliariello V; Del Vecchio V; Falco M; Luciano A; Amruthraj NJ; Nasti G; Ottaiano A; Berretta M; Iaffaioli RV; Arra C
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264501
[TBL] [Abstract][Full Text] [Related]
19. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
Wang X; Saso H; Iwamoto T; Xia W; Gong Y; Pusztai L; Woodward WA; Reuben JM; Warner SL; Bearss DJ; Hortobagyi GN; Hung MC; Ueno NT
Cancer Res; 2013 Nov; 73(21):6516-25. PubMed ID: 24014597
[TBL] [Abstract][Full Text] [Related]
20. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
Zhang Y
Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
